Skip to main content

Advertisement

SpringerLink
Log in

Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature

  • Review Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

It is not unusual that patients with systemic lupus erythematosus (SLE) progress to terminal renal failure and subsequently require renal replacement therapy. Previous studies have shown that clinical and/or serological remission in patients with SLE is common in those who develop end-stage renal disease (ESRD). On the other hand, the persistence of lupus activity among patients undergoing long-term dialysis is not rare, either. The aim of this study is to define, by means of a systematic review, the course of SLE activity in patients who developed ESRD. Data were obtained through searches for articles in the MEDLINE (1966 to 2011), SCielo, and LILACS databases, using the following keywords: “chronic renal failure”, “systemic lupus erythematosus”, “end-stage renal disease”, “lupus activity”, “disease activity”, “lupus flare”, “hemodialysis”, and “renal replacement therapy” and their corresponding translations in Portuguese. Twenty-four articles were found which evaluated the degree of lupus activity in patients with ESRD. Fifteen of these studies spoke of a substantial reduction of clinical and/or serological activity after the development of ESRD, while nine articles found that the amount of clinical and/or serological activity was similar to that of the phase prior to terminal renal failure, or it occurred in at least 50% of the patients studied. Although the majority of studies showed that lupus flares tend to decrease in frequency in patients who develop ESRD, in this scenario, one should be prepared to correctly diagnose a recurrence of the disease, as well as to perform appropriate therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. von Feldt JM (1995) Systemic lupus erythematosus. Recognizing its various presentations. Postgrad Med 97(4):79, 83, 86

    Google Scholar 

  2. Liang CC, Huang CC, Wang IK, Chang CT, Chen KH, Weng CH et al (2010) Impact of renal survival on the course and outcome of systemic lupus erythematosus patients treated with chronic peritoneal dialysis. Ther Apher Dial 14(1):35–42

    Article  PubMed  CAS  Google Scholar 

  3. Mojcik CF, Klippel JH (1996) End-stage renal disease and systemic lupus erythematosus. Am J Med 101(1):100–107

    Article  PubMed  CAS  Google Scholar 

  4. Nossent HC, Swaak TJ, Berden JH (1990) Systemic lupus erythematosus: analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Dutch Working Party on SLE. Am J Med 89(2):169–174

    Article  PubMed  CAS  Google Scholar 

  5. Wallace DJ, Podell TE, Weiner JM, Cox MB, Klinenberg JR, Forouzesh S et al (1982) Lupus nephritis. Experience with 230 patients in a private practice from 1950 to 1980. Am J Med 72(2):209–220

    Article  PubMed  CAS  Google Scholar 

  6. Brown CD, Rao TKS, Maxey RW, Butt KMH, Friedman EA (1979) Regression of clinical and immunological expression of systemic lupus erythematosus (SLE) consequent to development of uremia. Kidney Int 16:884

    Google Scholar 

  7. Cheigh JS, Stenzel KH, Rubin AL, Chami J, Sullivan JF (1983) Systemic lupus erythematosus in patients with chronic renal failure. Am J Med 75(4):602–606

    Article  PubMed  CAS  Google Scholar 

  8. Cheigh JS, Kim H, Stenzel KH, Tapia L, Sullivan JF, Stubenbord W et al (1990) Systemic lupus erythematosus in patients with end-stage renal disease: long-term follow-up on the prognosis of patients and the evolution of lupus activity. Am J Kidney Dis 16(3):189–195

    PubMed  CAS  Google Scholar 

  9. Coplon N, Siegel R, Fries J (1973) Hemodialysis on end-stage lupus nephritis. Trans Am Soc Artif Intern Organs 19:302–304

    Article  PubMed  CAS  Google Scholar 

  10. Coplon NS, Diskin CJ, Petersen J, Swenson RS (1983) The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 308(4):186–190

    Article  PubMed  CAS  Google Scholar 

  11. Correia P, Cameron JS, Ogg CS, Williams DG, Bewick M, Hicks JA (1984) End-stage renal failure in systemic lupus erythematosus with nephritis. Clin Nephrol 22(6):293–302

    PubMed  CAS  Google Scholar 

  12. Fries JF, Powers R, Kempson RL (1974) Late-stage lupus nephropathy. J Rheumatol 1(2):166–175

    PubMed  CAS  Google Scholar 

  13. Jarrett MP, Santhanam S, Del GF (1983) The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 143(7):1353–1356

    Article  PubMed  CAS  Google Scholar 

  14. Kang SH, Chung BH, Choi SR, Lee JY, Park HS, Sun IO et al (2011) Comparison of clinical outcomes by different renal replacement therapy in patients with end-stage renal disease secondary to lupus nephritis. Korean J Intern Med 26(1):60–67

    Article  PubMed  Google Scholar 

  15. Kimberly RP, Lockshin MD, Sherman RL, Beary JF, Mouradian J, Cheigh JS (1981) "End-stage" lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine (Baltimore) 60(4):277–287

    CAS  Google Scholar 

  16. Kobayashi M, Iitsuka T, Ishizu T, Hirayama K, Igarashi M, Yamaguchi N et al (1995) Clinicopathological study of dialysis patients with lupus nephritis. Nihon Jinzo Gakkai Shi 37(8):456–461

    PubMed  CAS  Google Scholar 

  17. Lee PT, Fang HC, Chen CL, Chiou YH, Chou KJ, Chung HM (2003) Poor prognosis of end-stage renal disease in systemic lupus erythematosus: a cohort of Chinese patients. Lupus 12(11):827–832

    Article  PubMed  Google Scholar 

  18. Okano K, Yumura W, Nitta K, Uchida K, Ohnuki T, Kawashima A et al (2001) Analysis of lupus activity in end-stage renal disease treated by hemodialysis. Intern Med 40(7):598–602

    Article  PubMed  CAS  Google Scholar 

  19. Szeto CC, Li PK, Wong TY, Leung CB, Lui SF (1998) Factors associated with active systemic lupus erythematosus after endstage renal disease. J Rheumatol 25(8):1520–1525

    PubMed  CAS  Google Scholar 

  20. Ribeiro FM, Leite MA, Velarde GC, Fabris CL, Santos RC, Lugon JR (2005) Activity of systemic lupus erythematosus in end-stage renal disease patients: study in a Brazilian cohort. Am J Nephrol 25(6):596–603

    Article  PubMed  Google Scholar 

  21. Bruce IN, Hallett DC, Gladman DD, Urowitz MB (1999) Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy. J Rheumatol 26(7):1490–1494

    PubMed  CAS  Google Scholar 

  22. Goo YS, Park HC, Choi HY, Kim BS, Park YB, Lee SK et al (2004) The evolution of lupus activity among patients with end-stage renal disease secondary to lupus nephritis. Yonsei Med J 45(2):199–206

    PubMed  Google Scholar 

  23. Krane NK, Burjak K, Archie M, O'donovan R (1999) Persistent lupus activity in end-stage renal disease. Am J Kidney Dis 33(5):872–879

    Article  PubMed  CAS  Google Scholar 

  24. Pahl MV, Vaziri ND, Saiki JK, Upham T, Ness R (1984) Chronic hemodialysis in end-stage lupus nephritis: changes of clinical and serological activities. Artif Organs 8(4):423–428

    Article  PubMed  CAS  Google Scholar 

  25. Rodby RA, Korbet SM, Lewis EJ (1987) Persistence of clinical and serologic activity in patients with systemic lupus erythematosus undergoing peritoneal dialysis. Am J Med 83(4):613–618

    Article  PubMed  CAS  Google Scholar 

  26. Sires RL, Adler SG, Louie JS, Cohen AH (1989) Poor prognosis in end-stage lupus nephritis due to nonautologous vascular access site associated septicemia and lupus flares. Am J Nephrol 9(4):279–284

    Article  PubMed  CAS  Google Scholar 

  27. Siu YP, Leung KT, Tong MK, Kwan TH, Mok CC (2005) Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 20(12):2797–2802

    Article  PubMed  Google Scholar 

  28. Stock GG Jr, Krane NK (1993) Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis. Adv Perit Dial 9:147–151

    PubMed  Google Scholar 

  29. Kaul H, Girndt M, Sester U, Sester M, Kohler H (2000) Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease. Am J Kidney Dis 35(4):611–616

    Article  PubMed  CAS  Google Scholar 

  30. Holdsworth SR, Fitzgerald MG, Hosking CS, Atkins RC (1978) The effect of maintenance dialysis on lymphocyte function. I. Haemodialysis. Clin Exp Immunol 33(1):95–101

    PubMed  CAS  Google Scholar 

  31. Kauffman CA, Manzler AD, Phair JP (1975) Cell-mediated immunity in patients on long-term haemodialysis. Clin Exp Immunol 22(1):54–61

    PubMed  CAS  Google Scholar 

  32. Austin HA III, Boumpas DT, Vaughan EM, Balow JE (1994) Predicting renal outcomes in severe lupus nephritis: contributions of clinical and histologic data. Kidney Int 45(2):544–550

    Article  PubMed  Google Scholar 

  33. Barr RG, Seliger S, Appel GB, Zuniga R, D'Agati V, Salmon J et al (2003) Prognosis in proliferative lupus nephritis: the role of socio-economic status and race/ethnicity. Nephrol Dial Transplant 18(10):2039–2046

    Article  PubMed  Google Scholar 

  34. Petri M, Perez-Gutthann S, Longenecker JC, Hochberg M (1991) Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. Am J Med 91(4):345–353

    Article  PubMed  CAS  Google Scholar 

  35. Ward MM, Studenski S (1990) Clinical manifestations of systemic lupus erythematosus. Identification of racial and socioeconomic influences. Arch Intern Med 150(4):849–853

    Article  PubMed  CAS  Google Scholar 

  36. Broder A, Khattri S, Patel R, Putterman C (2011) Undertreatment of disease activity in systemic lupus erythematosus patients with endstage renal failure is associated with increased all-cause mortality. J Rheumatol 38(11):2382–2389

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

MBS is currently receiving a scholarship from Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).

Disclosures

None.

Author information

Authors and Affiliations

  1. Federal University of Bahia, Salvador, Brazil

    Patrícia Mattos & Mittermayer B. Santiago

  2. Serviços Especializados em Reumatologia (SER) da Bahia, Salvador, Brazil

    Mittermayer B. Santiago

Authors
  1. Patrícia Mattos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mittermayer B. Santiago
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Mittermayer B. Santiago.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mattos, P., Santiago, M.B. Disease activity in systemic lupus erythematosus patients with end-stage renal disease: systematic review of the literature. Clin Rheumatol 31, 897–905 (2012). https://doi.org/10.1007/s10067-012-1957-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-012-1957-9

Keywords

Search

Navigation